February 9, 2015 / 2:53 PM / 3 years ago

BUZZ-Oncolytics Biotech Inc: Submits application for orphan drug status

** Canadian drug developer’s stock up 11 pct at 59 Canadian cents, U.S.-listed shares up 13 pct at 47.4 cents

** Says submitted application for orphan drug designation for its experimental drug to treat high grade gliomas in pediatric patients

** FDA grants orphan drug designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below